Nov 4th, 2009 - Reuters
Related topics:
* FDA advisory committee votes 5-1 against approval
* Advisers say data unclear, question long-term impact
* Zimmer says will make statement later (Adds details from meeting, quotes, byline)
GAITHERSBURG, Md., Nov 4 (Reuters) - A U.S. panel ofmedical experts on Wednesday recommended against wider use of aZimmer Holdings Inc (ZMH.N) spine stabilization device,questioning the company's data but adding that the device holdspromise.
Related stories:
Sacked drug tsar claims 'no independent scientist could work for Home Secretary'
Nov 2nd, 2009 - Telegraph
The furore over his departure has led to predictions of mass resignations from the country's drugs advisory panel which could leave the service in disarray. Dr Les King...
